Pricing Log in Create free account

Gossamer Bio, Inc. (GOSS) vs XBiotech Inc. (XBIT)

Gossamer Bio, Inc. and XBiotech Inc. are both Biotechnology companies. Gossamer Bio, Inc. and XBiotech Inc. are of similar size ($57.6M and $57.0M). Gossamer Bio, Inc. grew revenue faster over the last twelve months: 32.4% against −78.2%. XBiotech Inc. has the higher net margin (0.00% vs −235.0%) and the lower return on invested capital (−159.2% vs 0.00%). Across the 16 metrics below, XBiotech Inc. leads on 9 and Gossamer Bio, Inc. on 7.

Valuation

Metric GOSS XBIT Biotechnology median
P/E n/m n/m 10.60
P/S 0.73 14.29 9.40
P/B n/m 0.45 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.90 0.66
EV/Sales 4.07 (10.46) 9.02
Earnings yield (467.69%) (78.72%) (32.88%)
Free cash flow yield (417.17%) (71.50%) (23.13%)

Profitability

Metric GOSS XBIT Biotechnology median
Gross margin 100.00% 0.00% 68.51%
Operating margin (311.70%) 0.00% 0.00%
Net margin (235.00%) 0.00% 0.00%
Free cash flow margin (305.19%) 0.00% 0.00%
Return on equity 178.72% (29.94%) (51.96%)
Return on assets (78.81%) (28.90%) (46.06%)
Return on invested capital 0.00% (159.18%) 0.00%

Growth

Metric GOSS XBIT Biotechnology median
Revenue growth (TTM) 32.43% (78.20%) 6.76%
EPS growth (last fiscal year) (200.00%) (18.25%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GOSS XBIT Biotechnology median
Debt to equity (0.38) 0.00 0.00
Current ratio 0.53 33.15 4.97
Net debt to EBITDA (0.35) 2.33 1.01

Dividend

Metric GOSS XBIT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric GOSS XBIT Biotechnology median
Market cap 57.56m 57.01m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack